Skip to content

Homeopathy in the integrative treatment of knee osteoarthritis

Homeopathy in knee osteoarthritis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-8jc5dp
Enrollment
Unknown
Registered
2019-07-23
Start date
2019-04-10
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee osteoarthritis

Interventions

50 patients will be randomly allocated to treatment sequence A: 12 weeks of homeopathy and physiotherapy, 4 weeks of physiotherapy and placebo washout and 12 weeks of placebo and physiotherapy. 50 pa
Drug
Other
E02.095.682
H02.010.625
E02.760.169.063.500.387

Sponsors

Unidade de Saúde Escola da Universidade Federal de São Carlos
Lead Sponsor
Universidade Federal de São Carlos
Collaborator

Eligibility

Age
50 Years to 75 Years

Inclusion criteria

Inclusion criteria: Women and men 50 to 75 years old with a knee osteoarthritis diagnosis (according to the American College of Rheumatology criteria) in at least one knee compartment (tibiofemoral and/or patellofemoral).

Exclusion criteria

Exclusion criteria: Grade 1 or 4 in Kellgren and Lawrence radiologic classification of osteoarthritis; other inflammatory chronic diseases with musculoskeletal impairment; regular use of duloxetine or similar; use of anti-inflammatory drugs. Analgesic scape medication will be allowed.

Design outcomes

Primary

MeasureTime frame
In the group initially treated with homeopathy, we expect to find a 30% improvement of reported pain at week 12 (in relation to basal values), assessed through Visual Analog Scale for pain.

Secondary

MeasureTime frame
Compared to basal values, we expect to observe improvement in pain and mobility in all included patients at weeks 12 and 28. We also expect that that improvement will be significantly superior during homeopathy treatment periods, compared with placebo. Endpoints will be assessed by the following measures: Visual Analog Scale for pain; WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index); 40 meters fast paced walk test; Timed up and go test; 30 seconds chair-stand Test; analgesics load. Adverse Events will be registered throughout the entire study.

Countries

Brazil

Contacts

Public ContactUbiratan Adler

Unidade de Saúde Escola da Universidade Federal de São Carlos

ubiadler@outlook.com+55 16 3351-8926

Outcome results

None listed

Source: REBEC (via WHO ICTRP)